XML 30 R20.htm IDEA: XBRL DOCUMENT
v3.7.0.1

Segment Information | 6 Months Ended
--- | ---
Jun. 30, 2017
Segment Information [Abstract] |
Segment Information | 15. Segment Information We have two reportable segments organized according to our products and services: Medical Devices and Preservation Services. The Medical Devices segment includes external revenues from product sales of BioGlue® Surgical Adhesive; BioFoam® Surgical Matrix; On-X products, since the acquisition of On-X; CardioGenesis cardiac laser therapy; PerClot; PhotoFix; HeRO Graft, through the second quarter of 2016; and ProCol, through the date of the sale of the ProCol product line in the first quarter of 2016. The Preservation Services segment includes external services revenues from the preservation of cardiac and vascular tissues. There are no intersegment revenues. ﻿ The primary measure of segment performance, as viewed by our management, is segment gross margin, or net external revenues less cost of products and preservation services. We do not segregate assets by segment; therefore, asset information is excluded from the segment disclosures below. ﻿ The following table summarizes revenues, cost of products and preservation services, and gross margins for our operating segments (in thousands): ﻿
﻿ |  |  |  |  |  |  |  |  |  |  |
﻿ | Three Months Ended |  | Six Months Ended
﻿ | June 30, |  | June 30,
﻿ | 2017 |  | 2016 |  | 2017 |  | 2016
﻿Revenues: |  |  |  |  |  |  |  |  |  |  |
﻿Medical devices | $ | 30,094 |  | $ | 30,045 |  | $ | 57,490 |  | $ | 57,063
﻿Preservation services |  | 17,724 |  |  | 17,038 |  |  | 35,387 |  |  | 33,036
﻿Total revenues |  | 47,818 |  |  | 47,083 |  |  | 92,877 |  |  | 90,099
﻿ |  |  |  |  |  |  |  |  |  |  |
﻿Cost of products and preservation services: |  |  |  |  |  |  |  |  |  |  |
﻿Medical devices |  | 6,959 |  |  | 7,698 |  |  | 14,976 |  |  | 14,701
﻿Preservation services |  | 7,954 |  |  | 9,084 |  |  | 15,484 |  |  | 17,476
﻿Total cost of products and preservation services |  | 14,913 |  |  | 16,782 |  |  | 30,460 |  |  | 32,177
﻿ |  |  |  |  |  |  |  |  |  |  |
﻿Gross margin: |  |  |  |  |  |  |  |  |  |  |
﻿Medical devices |  | 23,135 |  |  | 22,347 |  |  | 42,514 |  |  | 42,362
﻿Preservation services |  | 9,770 |  |  | 7,954 |  |  | 19,903 |  |  | 15,560
﻿Total gross margin | $ | 32,905 |  | $ | 30,301 |  | $ | 62,417 |  | $ | 57,922
﻿ The following table summarizes net revenues by product and service (in thousands): ﻿ ﻿ ﻿ ﻿ ﻿ ﻿ ﻿ ﻿
﻿ |  |  |  |  |  |  |  |  |  |  |
﻿ | Three Months Ended |  | Six Months Ended
﻿ | June 30, |  | June 30,
﻿ | 2017 |  | 2016 |  | 2017 |  | 2016
﻿Products: |  |  |  |  |  |  |  |  |  |  |
﻿BioGlue and BioFoam | $ | 16,683 |  | $ | 16,187 |  | $ | 32,364 |  | $ | 31,503
﻿On-X |  | 9,862 |  |  | 9,554 |  |  | 18,722 |  |  | 16,269
﻿CardioGenesis cardiac laser therapy |  | 2,056 |  |  | 1,860 |  |  | 3,641 |  |  | 3,844
﻿PerClot |  | 936 |  |  | 1,042 |  |  | 1,755 |  |  | 2,033
﻿PhotoFix |  | 557 |  |  | 490 |  |  | 1,008 |  |  | 871
﻿HeRO Graft |  | -- |  |  | 912 |  |  | -- |  |  | 2,325
﻿ProCol |  | -- |  |  | -- |  |  | -- |  |  | 218
﻿Total products |  | 30,094 |  |  | 30,045 |  |  | 57,490 |  |  | 57,063
﻿ |  |  |  |  |  |  |  |  |  |  |
﻿Preservation services: |  |  |  |  |  |  |  |  |  |  |
﻿Cardiac tissue |  | 8,477 |  |  | 7,548 |  |  | 15,979 |  |  | 13,976
﻿Vascular tissue |  | 9,247 |  |  | 9,490 |  |  | 19,408 |  |  | 19,060
﻿Total preservation services |  | 17,724 |  |  | 17,038 |  |  | 35,387 |  |  | 33,036
﻿ |  |  |  |  |  |  |  |  |  |  |
﻿Total revenues | $ | 47,818 |  | $ | 47,083 |  | $ | 92,877 |  | $ | 90,099
﻿ ﻿

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -URI http://asc.fasb.org/topic&trid=2134510 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration